Fagron Q1 Revenue Climbs 10.3% to €263.4 Million

Fagron Reports Strong First-Quarter Growth

Fagron, the Belgium and Netherlands-based pharmaceutical compounding firm, announced first-quarter revenue of €263.4 million. This figure represents a 10.3 percent increase compared to the same period last year.

The company also reported organic growth of 3.2 percent at constant exchange rates, indicating solid underlying performance across its operations.

Global Performance and Strategic Acquisitions

Growth was observed across all regions. Latin America was a standout performer, delivering 10.4 percent organic growth at constant exchange rates, largely driven by a successful Brands strategy in Brazil. The EMEA region also made a positive contribution to the revenue expansion.

During the quarter, Fagron successfully completed its acquisition of Pharmavit in the Netherlands. The company confirmed that the integration process is progressing as planned and the transaction supported overall revenue growth.

Future Outlook and Projections

Looking ahead to the full year 2026, Fagron anticipates organic sales growth in the mid-to-high single digits at constant exchange rates. The company is targeting a REBITDA margin of approximately 20 percent.

Fagron's management expects business to accelerate starting in the second quarter, with a notably stronger performance anticipated in the second half of the year. This projection suggests growing confidence in its strategic initiatives and market position.

Summary

Fagron's first-quarter results demonstrate robust growth fueled by strong regional performance, particularly in Latin America, and strategic acquisitions. The company maintains a positive outlook, forecasting continued organic growth and margin improvement, with an expected acceleration in the latter half of the year.

FAQ

Q: What was Fagron's total revenue in the first quarter?

A: Fagron reported first-quarter revenue of €263.4 million, a 10.3 percent increase year-over-year.

Q: Which region showed the strongest growth for Fagron?

A: Latin America delivered the strongest performance with 10.4 percent organic growth at constant exchange rates.

Q: What is Fagron's financial outlook?

A: For 2026, Fagron expects mid-to-high single-digit organic sales growth and a REBITDA margin of around 20 percent.

Source: Investing.com